Information  X 
Enter a valid email address

Sirius Real Estate (SRE)

  Print      Mail a friend

Friday 27 March, 2020

Sirius Real Estate

Dealing In Securities By Employee Benefit Trust

RNS Number : 9269H
Sirius Real Estate Limited
27 March 2020
 

SIRIUS REAL ESTATE LIMITED

(Incorporated in Guernsey)

Company Number: 46442

JSE Share Code: SRE

LSE (GBP) Share Code: SRE

LSE (EUR) Share Code: ESRE

LEI: 213800NURUF5W8QSK566

ISIN Code: GG00B1W3VF54

 

27 March 2020

Sirius Real Estate Limited

("Sirius Real Estate", "Sirius" or the "Company")

Dealing In Securities By Sirius Real Estate Employee Benefit Trust

 

In compliance with paragraphs 3.63 to 3.74 and 3.92 of the JSE Limited Listings Requirements, the following information regarding the dealing in securities is disclosed:

 

NAME OF PURCHASER

Sirius Real Estate Employee Benefit Trust (" Trust ")

COMPANY TO WHICH THE DEALING RELATES

Sirius Real Estate Limited

TYPE AND CLASS OF SECURITIES

Ordinary shares of no par value

NATURE OF TRANSACTIONS

Purchases of shares by the Trust to enable it to satisfy awards made or to be made under the Company's share incentive schemes
(On-market)

PLACE OF TRANSACTIONS

London Stock Exchange (XLON)

DATE OF TRANSACTIONS

25 March 2020

DATE OF NOTIFICATIONS

26 March 2020

PRICE PER SECURITY

Average: £0.595

High: £0.600

Low: £0.580

NUMBER OF SECURITIES TRANSACTED

612,720

TOTAL VALUE OF SECURITIES TRANSACTED

£364,568.40

 

Clearance for the above was obtained in terms of paragraph 3.66 of the JSE Limited Listings Requirements.

 

For further information:

Sirius Real Estate

Andrew Coombs, CEO

Alistair Marks, CFO

+49 (0)30 285 010 110





Tavistock

Jeremy Carey

James Verstringhe

 

+44 (0)20 7920 3150

JSE Sponsor

PSG Capital


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCEDLFLBXLZBBV

a d v e r t i s e m e n t